Skip to content

osaühing TAULA PHARMA

Registry code (registrikood) 11277584Private limited company (Osaühing)VAT EE101073635Activity (EMTAK 73111): Reklaamiagentuuride tegevusActive

Tallinn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€1.3M
▲ 20.7% vs 2024
Profit before tax (2025)
-€16k
Employees, FTE (2025)
11
State taxes paid, last 4 quarters
€286k

Revenue, profit and employees, 2019–2025

€211k2019€306k2020€678k2021€938k2022€945k2023€1.1M2024€1.3M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2019€211,442-€74,077-€74,067€76,4354
2020€306,016€6,904€6,908€83,3434
2021€677,899€23,837€23,840€107,1839
2022€938,077€8,643€8,648€115,83111
2023€944,937€33,487€34,486€150,31710
2024€1,087,052€14,622€16,616€166,93310
2025€1,311,763-€15,960-€15,714€151,22011

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2019€36,075€101,483€25,048—€76,435
2020€43,349€115,787€32,444—€83,343
2021€59,998€188,684€81,501—€107,183
2022€87,297€197,980€82,149—€115,831
2023€143,537€275,969€125,652—€150,317
2024€192,681€357,811€190,878—€166,933
2025€149,329€282,284€131,064—€151,220

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€45,738€45,619€258,92710
2022 Q2€51,632€52,432€238,95810
2022 Q3€50,265€52,614€242,51012
2022 Q4€58,921€60,637€290,2639
2023 Q1€45,471€46,702€230,3498
2023 Q2€53,482€54,959€248,0219
2023 Q3€49,235€50,458€264,0717
2023 Q4€40,463€40,717€319,5219
2024 Q1€49,270€49,782€307,2059
2024 Q2€59,697€61,555€295,8199
2024 Q3€55,891€58,127€275,1289
2024 Q4€57,749€58,352€390,4527
2025 Q1€52,760€54,850€310,6249
2025 Q2€57,854€61,055€437,06410
2025 Q3€66,363€69,756€399,16410
2025 Q4€67,456€70,345€499,07510
2026 Q1€61,659€62,198€448,22310
2026 Q2€75,593€77,963€423,89612
2026 Q3€81,336€84,622€536,10612

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), osaühing TAULA PHARMA reported revenue of €1,311,763.

The company recorded a net loss of €15,714 in the 2025 financial year.

Revenue increased by 20.7% from €1,087,052 in 2024 to €1,311,763 in 2025.

Revenue grew at a compound annual rate of 35.6% between 2019 and 2025.

Equity accounted for 53.6% of total assets of €282,284 at the end of the 2025 reporting period.

With 11 full-time-equivalent employees in 2025, revenue per employee was €119,251.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, osaühing TAULA PHARMA reported €1,907,300 in turnover.

EMTA recorded 12 employees for the quarter ending Q3 2026, compared with 11 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.